Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
89bio ( (ETNB) ) has provided an announcement.
On December 12, 2024, 89bio, Inc. granted restricted stock units to key employees, including the Chief Medical Officer, Chief Technical Operations Officer, and Chief Financial Officer, as part of a retention strategy. This move is aimed at ensuring their continued service with the company, with the RSUs vesting semiannually over two years, potentially strengthening the company’s operational stability and retaining top talent.
More about 89bio
89bio, Inc. is a biopharmaceutical company focused on developing treatments for liver and cardio-metabolic diseases.
YTD Price Performance: -31.15%
Average Trading Volume: 790,338
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $904.2M
For detailed information about ETNB stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Tesla Stock Upgraded to Buy by Mizuho with a New Street-High Price Target
- 3 Penny Stocks to Watch Now, 12/17/24
- TikTok Urges U.S. Supreme Court to Halt the Ban While Meta and Google Relish
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
